Vivo Capital, LLC Q1 2018 Filing
Filed May 15, 2018
Portfolio Value
$705.9B
Holdings
34
Report Date
Q1 2018
Filing Type
13F-HR
All Holdings (34 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —Menlo Therapeutics | 4,011,236 | $150.7B | 21.35% | |
| 2 | ASNDAscendis Pharma | 2,166,832 | $141.7B | 20.07% | |
| 3 | —Biohaven Pharmaceutical Holding Company Ltd | 2,049,545 | $52.8B | 7.48% | |
| 4 | CDXSCodexis, Inc. | 3,054,825 | $33.6B | 4.76% | |
| 5 | APLSApellis Pharmaceuticals, Inc. | 1,457,834 | $32.2B | 4.57% | |
| 6 | VRNAVerona Pharma Plc | 1,492,951 | $29.9B | 4.23% | |
| 7 | ACRSAclaris Therapeutics | 1,647,214 | $28.9B | 4.09% | |
| 8 | FIXXEURHomology Medicines, Inc. | 1,159,742 | $21.7B | 3.07% | |
| 9 | —Nabriva Therapeutics Plc | 4,074,190 | $20.5B | 2.90% | |
| 10 | AMRSEURAmyris, Inc. | 2,826,711 | $18.9B | 2.68% | |
| 11 | CLDNEUREiger BioPharmaceuticals | 1,791,257 | $17.6B | 2.50% | |
| 12 | —Strongbridge Biopharma plc | 1,918,132 | $17.0B | 2.40% | |
| 13 | KALAKala Pharmaceuticals, Inc. | 1,043,020 | $16.5B | 2.34% | |
| 14 | —Kadmon Holdings (KDMN) | 3,333,333 | $14.2B | 2.01% | |
| 15 | ARWRArrowhead Pharmaceuticals Inc | 1,900,000 | $13.7B | 1.94% | |
| 16 | SELBUSDSelecta Biosciences, Inc. | 1,119,189 | $11.4B | 1.62% | |
| 17 | CBAYUSDCymabay Therapeutics Inc | 800,000 | $10.4B | 1.47% | |
| 18 | —Aimmune Therapeutics, Inc. | 306,872 | $9.8B | 1.38% | |
| 19 | —Genocea Biosciences Inc | 8,180,000 | $8.6B | 1.22% | |
| 20 | —Soleno Therapeutics, Inc. | 4,033,534 | $7.3B | 1.04% | |
| 21 | AUPHAurinia Pharmaceuticals Inc. | 1,213,290 | $6.3B | 0.89% | |
| 22 | ZLABZai Lab LTD | 283,787 | $6.1B | 0.86% | |
| 23 | —Sierra Oncology, Inc | 2,438,270 | $5.0B | 0.71% | |
| 24 | RGNXRegenxbio Inc. | 164,403 | $4.9B | 0.70% | |
| 25 | —Foamix Pharmaceuticals Ltd. | 855,000 | $4.4B | 0.62% | |
| 26 | —Zogenix, Inc. | 105,000 | $4.2B | 0.60% | |
| 27 | —Agile Therapeutics, Inc. | 1,513,975 | $3.9B | 0.55% | |
| 28 | —BioPharmX Corporation | 16,128,515 | $3.7B | 0.53% | |
| 29 | MDGLMadrigal Pharmaceuticals Inc | 27,220 | $3.2B | 0.45% | |
| 30 | KALVKalVista Pharmaceuticals, Inc. | 300,325 | $2.8B | 0.40% | |
| 31 | —Trevena, Inc. | 1,728,000 | $2.8B | 0.40% | |
| 32 | —Akari Therapeutics Plc | 345,850 | $629.0M | 0.09% | |
| 33 | —Sunesis Pharmaceuticals, Inc. | 195,474 | $532.0M | 0.08% | |
| 34 | —Soleno Therapeutics, Inc. | 188,772 | $23.0M | 0.00% |